News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,496 Results
Type
Article (42225)
Company Profile (296)
Press Release (670975)
Section
Business (210328)
Career Advice (2094)
Deals (36621)
Drug Delivery (105)
Drug Development (82977)
Employer Resources (172)
FDA (16538)
Job Trends (15385)
News (355804)
Policy (33866)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2583)
Accelerated approval (2)
Adcomms (21)
Allergies (80)
Alliances (51338)
ALS (78)
Alzheimer's disease (1340)
Antibody-drug conjugate (ADC) (106)
Approvals (16521)
Artificial intelligence (225)
Autoimmune disease (10)
Automation (14)
Bankruptcy (367)
Best Places to Work (11771)
BIOSECURE Act (19)
Biosimilars (98)
Biotechnology (190)
Bladder cancer (50)
Brain cancer (25)
Breast cancer (234)
Cancer (1823)
Cardiovascular disease (140)
Career advice (1749)
Career pathing (29)
CAR-T (132)
Cell therapy (378)
Cervical cancer (13)
Clinical research (66939)
Collaboration (716)
Compensation (403)
Complete response letters (24)
COVID-19 (2641)
CRISPR (36)
C-suite (183)
Cystic fibrosis (100)
Data (1724)
Decentralized trials (2)
Denatured (24)
Depression (38)
Diabetes (227)
Diagnostics (6386)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (107)
Drug pricing (106)
Drug shortages (27)
Duchenne muscular dystrophy (65)
Earnings (87414)
Editorial (29)
Employer branding (21)
Employer resources (148)
Events (114070)
Executive appointments (603)
FDA (17525)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (640)
Gene editing (91)
Generative AI (20)
Gene therapy (270)
GLP-1 (697)
Government (4488)
Grass and pollen (4)
Guidances (46)
Healthcare (18973)
Huntington's disease (23)
IgA nephropathy (20)
Immunology and inflammation (98)
Indications (24)
Infectious disease (2761)
Inflammatory bowel disease (129)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (72)
Interviews (323)
IPO (16748)
IRA (47)
Job creations (4054)
Job search strategy (1494)
Kidney cancer (9)
Labor market (26)
Layoffs (464)
Leadership (15)
Legal (8359)
Liver cancer (70)
Lung cancer (262)
Lymphoma (122)
Machine learning (2)
Management (58)
Manufacturing (256)
MASH (59)
Medical device (13371)
Medtech (13376)
Mergers & acquisitions (20271)
Metabolic disorders (601)
Multiple sclerosis (59)
NASH (17)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1783)
NextGen: Class of 2025 (6635)
Non-profit (4524)
Northern California (2227)
Now hiring (35)
Obesity (331)
Opinion (221)
Ovarian cancer (62)
Pain (80)
Pancreatic cancer (70)
Parkinson's disease (118)
Partnered (17)
Patents (185)
Patient recruitment (81)
Peanut (48)
People (58893)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20757)
Phase II (29457)
Phase III (22066)
Pipeline (813)
Podcasts (70)
Policy (113)
Postmarket research (2654)
Preclinical (8775)
Press Release (68)
Prostate cancer (85)
Psychedelics (31)
Radiopharmaceuticals (247)
Rare diseases (350)
Real estate (6248)
Recruiting (66)
Regulatory (22854)
Reports (43)
Research institute (2363)
Resumes & cover letters (358)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (66)
Series A (117)
Series B (69)
Service/supplier (12)
Sickle cell disease (52)
Southern California (1905)
Special edition (14)
Sponsored (29)
Startups (3719)
State (2)
Stomach cancer (12)
Supply chain (57)
The Weekly (45)
United States (19667)
Vaccines (645)
Venture capitalists (34)
Webinars (12)
Weight loss (232)
Women's health (30)
Worklife (13)
Date
Today (167)
Last 7 days (775)
Last 30 days (3020)
Last 365 days (34826)
2025 (5832)
2024 (35771)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27631)
2012 (29731)
2011 (30487)
2010 (28497)
Location
Africa (780)
Alabama (48)
Alaska (7)
Arizona (220)
Arkansas (13)
Asia (40440)
Australia (6480)
California (5079)
Canada (1771)
China (425)
Colorado (233)
Connecticut (241)
Delaware (114)
Europe (86217)
Florida (745)
Georgia (173)
Idaho (57)
Illinois (477)
India (21)
Indiana (283)
Iowa (7)
Japan (130)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (781)
Massachusetts (3895)
Michigan (203)
Minnesota (349)
Mississippi (2)
Missouri (71)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1447)
New Mexico (28)
New York (1451)
North Carolina (888)
North Dakota (7)
Northern California (2227)
Ohio (177)
Oklahoma (13)
Oregon (37)
Pennsylvania (1154)
Puerto Rico (6)
Rhode Island (23)
South America (1159)
South Carolina (14)
South Dakota (1)
Southern California (1905)
Tennessee (84)
Texas (749)
Utah (157)
Virginia (124)
Washington D.C. (55)
Washington State (485)
West Virginia (3)
Wisconsin (46)
713,496 Results for "crinetics pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
February 24, 2025
·
6 min read
Press Releases
Crinetics Pharmaceuticals to Participate in Two Upcoming March 2025 Investor Conferences
February 21, 2025
·
1 min read
Press Releases
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 27, 2025
·
12 min read
Press Releases
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 6, 2025
·
1 min read
Press Releases
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 11, 2025
·
2 min read
Press Releases
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer
December 16, 2024
·
7 min read
Press Releases
Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Biotech Beach
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 10, 2024
Crinetics Pharmaceuticals, Inc. announced that on June 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 158,000 shares of its common stock to nine new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan.
June 10, 2024
·
2 min read
Business
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced the appointment of Robert M. Cuddihy, M.D., as senior vice president of Medical Affairs.
May 30, 2024
·
4 min read
Biotech Beach
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
Crinetics Pharmaceuticals, Inc. announced that the late-breaking abstracts accepted for presentation at the Endocrine Society’s annual meeting were released earlier than the previously announced embargoed date.
May 22, 2024
·
3 min read
1 of 71,350
Next
